Nd. Jeffery et al., Behavioural consequences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord, EUR J NEURO, 11(5), 1999, pp. 1508-1514
Glial cell transplantation has the potential to be developed into a clinica
l treatment for human demyelinating diseases because of its demonstrated ef
ficacy in remyelinating experimentally demyelinated axons. As a step toward
s clinical application it is necessary to demonstrate that the procedure is
safe and efficacious in promoting behavioural recovery, In this study we t
ransplanted glial cell progenitors into demyelinating lesions induced by in
traspinal injection of ethidium bromide in the rat. Locomotor function afte
r transplantation was assessed using a beam-walking test that has previousl
y been shown able to detect deficits associated with demyelination in the d
orsal funiculus of the rat spinal card. Two groups of animals with transpla
nts were examined. In one group, spontaneous remyelination was prevented by
exposure of the lesion to 40 Gy of X-irradiation; in the other, male glial
cells were transplanted into nonirradiated female receipients, permitting
their identification by use of a probe specific to the rat Y chromosome. Fo
llowing transplantation, there was severe axon loss in a large proportion o
f the irradiated animals and those affected did not recover normal behaviou
ral function. In contrast, both the small proportion of the irradiated grou
p that sustained only mild axon loss and the nonirradiated recipients of tr
ansplants recovered normal function on our behavioural test. We conclude th
at glial cell transplantation is able to reverse the functional deficits as
sociated with demyelination, provided axonal loss is minimal.